Ghrelin, the hormone of the gastric fundus, is an attractive target for obesity and T2DM, since it promotes insulin resistance and hyperglycemia [5, 15]. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.